Histology Equipment Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032
Published on: 2024-08-03 | No of Pages : 240 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
Histology Equipment Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032
Histology Equipment Market Size
Histology Equipment Market size is poised to witness remarkable gains from 2024 to 2032 due to the rising prevalence of skin cancer and the ongoing innovations in cutting-edge treatment technologies. The growing burden of skin conditions worldwide has prompted extensive R&D efforts and the expansion of novel technologies, such as artificial intelligence (AI) and robotics.
For instance, the Ozcan Research Group designed a new technology called Virtual Histology at the University of California, Los Angeles (UCLA) in 2022. The technology deploys next-generation AI and deep learning models to reflectance confocal microscopy (RCM) images for performing in vivo histology of the RCM images associated with basal cell carcinoma, and melanocytic nevi. Similar developments in the field of AI-enabled histology equipment will drive the industry progress.
Histology Equipment Market Trends
The demand for personalized medicine is driving the development of high-throughput systems capable of analyzing diverse tissue samples rapidly. Also, there is growing focus on eco-friendly and sustainable practices, that is leading to the adoption of greener technologies in histology equipment manufacturing. Lastly, the improving healthcare infrastructure and increasing research activities will shape the histology equipment industry outlook in the coming years.
Histology Equipment Market Analysis
The slide staining systems segment is poised to record heightened demand through 2032, due to high diagnostic accuracy. The automation of laboratory processes and the integration of digital pathology solutions have increased the product usage as it offers consistency, reproducibility, and workflow efficiency. Furthermore, the expanding application of histology techniques in research, drug development, and biotechnology sectors is contributing to the increased demand for slide staining systems, as they facilitate rapid and reliable sample preparation for various downstream analyses.
Diagnostic centers segment will hold significant industry share by 2032, owing to the surging number of clinical autopsies performed in these centers. Additionally, the increasing incidences of infectious diseases and the growing emphasis on early diagnosis will further accelerate the adoption of tissue processors, tissue embedders, cryostats, and microtomes. The growing usage of histology equipment in diagnostic centers as they offer tissue protection, reliability, and built-in quality will further add to the market revenues.
North America histology equipment market size is poised to record substantial expansion between 2024 and 2032, attributed to the presence of the well-established healthcare infrastructure. The growing patient awareness regarding skin treatment and the rising healthcare expenditure are other factors driving the industry dynamics. Over the past few years, the prevalence of skin cancer in the U.S. has increased significantly, leading to the higher demand for histology equipment.
According to the International Agency for Research on Cancer (IARC), the annual prevalence of cutaneous melanoma is projected to rise by more than 50% from 2020 to 2040. Additionally, the promising integration of AI, machine learning, and other cutting-edge technologies have led to increased product adoption.
Histology Equipment Market Share
The competitive landscape of the histology equipment industry includes players, such as
- BioGenex
- Biocare Medical LLC.
- F. Hoffman-La-Roche
- Merck KGaA
- Leica Biosystems Nussloch GmbH
- Sakura Finetek
- Ted PellaInc.
- Intelsint Srl
- Thermo Fisher Scientific
- Agilent Technologies Inc.
Histology Equipment Industry News
- In November 2022, Biocare Medical acquired Empire Genomics, a prominent player in molecular biomarkers for cancer research and diagnostics. This acquisition augmented their extensive portfolio of IHC antibodies, comprehensive molecular menu, and advanced automation platforms.